Cardiac-specific beta-blockers and asthma: An end to fear?
- PMID: 33210754
- DOI: 10.1111/resp.13979
Cardiac-specific beta-blockers and asthma: An end to fear?
Keywords: asthma; beta-blocker; bisoprolol, bronchoconstriction.
Comment on
-
The impact of regular bisoprolol on the response to salbutamol in asthma: A double-blind randomized placebo-controlled crossover trial.Respirology. 2021 Mar;26(3):225-232. doi: 10.1111/resp.13955. Epub 2020 Oct 11. Respirology. 2021. PMID: 33043552 Clinical Trial.
References
REFERENCES
-
- Frishman W. Fifty years of beta-blockers: a revolution in CV pharmacotherapy. Cardiology Today 2008. Available from URL: https://www.healio.com/news/cardiology/20120225/fifty-years-of-beta-bloc....
-
- Baker JG, Hill SJ, Summers RJ. Evolution of b-blockers: from anti-anginal drugs to ligand-directed signalling. Trends Pharmacol. Sci. 2011; 32: 227-34.
-
- Harries A. Beta-blockades in asthma. Br. Med. J. 1981; 282: 1321.
-
- Morales DR, Lipworth BJ, Donnan PT, Jackson C, Guthrie B. Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case. BMC Med. 2017; 15: 1-9.
-
- Bennet M, Chang C, Teffery C, Hopping S, Hancox B. The impact of regular bisoprolol on the response to salbutamol in asthma: a double-blind randomized placebo-controlled crossover trial. Respirology 2021; 26: 225-32.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
